The global antihypertensive drugs market is estimated to grow at 1.2%
during the forecast period, to reach USD 30 billion. Hypertension is a
lifelong disease, which means that a patient may require to take
medications every day for the rest of his/her life. Thus, the demand for
anti-hypertensive dugs is sustainable and will increase with the
rapidly increasing aging population.
This report studies Antihypertensive Drugs in Global and China market, focuses on price, sales, revenue of each type in global China. This report also focuses on the sales (consumption), production, import and export of Antihypertensive Drugs in North America, Japan, Europe, India, Southeast Asia and China, forecast to 2020, from 2015.
Split by product types, with sales, revenue, market share and price of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers, in 2015 and 2016, covering
Diuretics
Calcium channel blockers (CCB)
ACE inhibitors (ACE-I)
Angiotensin II receptor antagonists (ARB)
Adrenergic receptor antagonists
Vasodilators
Benzodiazepines
Renin Inhibitors
Aldosterone receptor antagonists
Alpha-2 adrenergic receptor agonists
This report studies Antihypertensive Drugs in Global and China market, focuses on price, sales, revenue of each type in global China. This report also focuses on the sales (consumption), production, import and export of Antihypertensive Drugs in North America, Japan, Europe, India, Southeast Asia and China, forecast to 2020, from 2015.
Split by product types, with sales, revenue, market share and price of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers, in 2015 and 2016, covering
Diuretics
Calcium channel blockers (CCB)
ACE inhibitors (ACE-I)
Angiotensin II receptor antagonists (ARB)
Adrenergic receptor antagonists
Vasodilators
Benzodiazepines
Renin Inhibitors
Aldosterone receptor antagonists
Alpha-2 adrenergic receptor agonists
No comments:
Post a Comment